HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
  Home
How technology is guiding COVID-19 response worldwide
Latest Videos

How technology is guiding COVID-19 response worldwide

4:03

Health systems all over the world are addressing the needs of COVID-19 patients with chatbots, drive-through clinics and telemedicine.

Read More
Read Less

Latest Videos - Similar Videos View more in Latest Videos

12:04

Space is a living laboratory for new care models

Dr. Scott Parazynski, founder and CEO of OnwardAir, says that innovations created to treat astronauts in the extreme environment of space have the potential to improve remote care and aging research on Earth.

Space is a living laboratory for new care models
Dr. Scott Parazynski, founder and CEO of OnwardAir, says that innovations created to treat astronauts in the extreme environment of space have the potential to improve remote care and aging research on Earth.
12:04
5:13

Predicting OR demand with 90% accuracy at RUSH

In the second part of our look at the Chicago medical center's returns on OR analytics investments, Sam Davis Jr., AVP of perioperative and interventional clinical services, says "trusted data and transparency made all the difference."

Predicting OR demand with 90% accuracy at RUSH
In the second part of our look at the Chicago medical center's returns on OR analytics investments, Sam Davis Jr., AVP of perioperative and interventional clinical services, says "trusted data and transparency made all the difference."
5:13
10:54

Redefining aging as a treatable condition

Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.

Redefining aging as a treatable condition
Alex Aliper, Insilico Medicine's president, says that longevity progress is already being made, but that regulators need to classify aging as a disease and track its biomarkers to enable more therapeutic advances.
10:54